Finoriq research workspace
BIOLIFE SOLUTIONS INC (BLFS) SEC Filings & Filing Highlights
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services. Review BLFS SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
- Company
- BIOLIFE SOLUTIONS INC (BLFS)
- Ticker
- BLFS
- Market Cap
- $1.4B
- Latest Price
- $29.13
- Industry
- Medical Devices
BIOLIFE SOLUTIONS INC (BLFS) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BIOLIFE SOLUTIONS INC (BLFS).
| Event | Form | Date |
|---|---|---|
| On June 3, 2026, BioLife Solutions, Inc. issued an investor presentation. A copy of the present...On June 3, 2026, BioLife Solutions, Inc. (the “Company”) issued an investor presentation. A copy of the presentation is furnished as Exhibi... | 8-K7.01 | 2026-06-03 |
| BIOLIFE SOLUTIONS INC: Earnings or resultsOn May 7, 2026, BioLife Solutions, Inc. (the “Company”) issued a press release announcing unaudited financial results and operational highl... | 8-K2.02 | 2026-05-07 |
| On March 2, 2026, BioLife Solutions, Inc., issued an investor presentation. A copy of the prese...On March 2, 2026, BioLife Solutions, Inc. ("the Company"), issued an investor presentation. A copy of the presentation is furnished as Exhi... | 8-K7.01 | 2026-03-02 |
| BIOLIFE SOLUTIONS INC: Earnings or resultsOn February 26, 2026, BioLife Solutions, Inc. ("the Company"), a Delaware corporation, issued a press release announcing financial results... | 8-K2.02 | 2026-02-26 |
| BIOLIFE SOLUTIONS INC: Earnings or resultsOn January 12, 2026, the BioLife Solutions, Inc. (the “Company”) issued a press release announcing its preliminary unaudited revenue for th... | 8-K2.02 | 2026-01-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.